A Comparison of the Empirical Performance of Methods for a Risk Identification System

Proton pump inhibitors and the risk of pneumonia: a comparison of cohort and self-controlled case series designs

(2013) Emmae N Ramsay et al.   BMC Medical Research Methodology

Empirical Performance of the Calibrated Self-Controlled Cohort Analysis Within Temporal Pattern Discovery: Lessons for Developing a Risk Identification and Analysis System

(2013) G. Niklas Norén et al.   DRUG SAFETY

Empirical Performance of the Self-Controlled Case Series Design: Lessons for Developing a Risk Identification and Analysis System

(2013) Marc A. Suchard et al.   DRUG SAFETY

Empirical Performance of a Self-Controlled Cohort Method: Lessons for Developing a Risk Identification and Analysis System

(2013) Patrick B. Ryan et al.   DRUG SAFETY

Empirical Performance of the Case–Control Method: Lessons for Developing a Risk Identification and Analysis System

(2013) David Madigan et al.   DRUG SAFETY

Empirical Performance of LGPS and LEOPARD: Lessons for Developing a Risk Identification and Analysis System

(2013) Martijn J. Schuemie et al.   DRUG SAFETY

Defining a Reference Set to Support Methodological Research in Drug Safety

(2013) Patrick B. Ryan et al.   DRUG SAFETY

Empirical Performance of a New User Cohort Method: Lessons for Developing a Risk Identification and Analysis System

(2013) Patrick B. Ryan et al.   DRUG SAFETY

Evaluation of Disproportionality Safety Signaling Applied to Healthcare Databases

(2013) William DuMouchel et al.   DRUG SAFETY

A Reference Standard for Evaluation of Methods for Drug Safety Signal Detection Using Electronic Healthcare Record Databases

(2012) Preciosa M. Coloma et al.   DRUG SAFETY

Classification of epidemiological study designs

(2012) N. Pearce   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Using Electronic Health Care Records for Drug Safety Signal Detection

(2012) Martijn J. Schuemie et al.   MEDICAL CARE

Design considerations in an active medical product safety monitoring system

(2012) Joshua J. Gagne et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

When should case-only designs be used for safety monitoring of medical products?

(2012) Malcolm Maclure et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership

(2012) Patrick B. Ryan et al.   STATISTICS IN MEDICINE

Within-person study designs had lower precision and greater susceptibility to bias because of trends in exposure than cohort and nested case–control designs

(2011) Jennifer M. Nicholas et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Risk of Acute Myocardial Infarction, Stroke, Heart Failure, and Death in Elderly Medicare Patients Treated With Rosiglitazone or Pioglitazone

(2010) David J. Graham et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A basic study design for expedited safety signal evaluation based on electronic healthcare data

(2010) Sebastian Schneeweiss   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Rapid Identification of Myocardial Infarction Risk Associated With Diabetes Medications Using Electronic Medical Records

(2009) J. S. Brownstein et al.   DIABETES CARE

Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?

(2009) Gianluca Trifirò et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Adverse Event Detection in Drug Development: Recommendations and Obligations Beyond Phase 3

(2008) Jesse A. Berlin et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Risk of ischaemic cardiovascular events from selective cyclooxygenase-2 inhibitors in osteoarthritis

(2008) Marianne Cunnington et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY